CO-DIAGNOSTICS INC
CODX · NASDAQ
Updated at 2026-10-13 15:18:11
- Today's High
- $1.25
- Today’s Low
- $1.14
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.12
- Previous Close
- $1.25
- Volume
- 652.97K
- Market Cap
- $9.3M
- P/E Ratio
- --
- EPS
- $-23.84
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- 2401 S. FOOTHILL DRIVE, SALT LAKE CITY, UT, UNITED STATES, 84109
- Country
- US
- Listing Date
- 2017-07-12
- Fiscal Year End
- December
- Shares Outstanding
- 5.28M
- CIK
- 0001692415
- Website
- codiagnostics.com
Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.
Financial Metrics
Revenue
2026-06-30
$166.13K
2026-03-31
$145.95K
2025-12-31
$263.92K
2025-09-30
$145.38K
Operating Expenses
2026-06-30
$6.32M
2026-03-31
$8.9M
2025-12-31
$7.78M
2025-09-30
$7.13M
Net Income
2026-06-30
-$6.28M
2026-03-31
-$9.14M
2025-12-31
-$25.74M
2025-09-30
-$5.88M
Net Profit Margin
2026-06-30
-3.78K%
2026-03-31
-6.26K%
2025-12-31
-9.75K%
2025-09-30
-4.04K%
Earnings Per Share
2026-06-30
$-1.46
2026-03-31
$-4.09
2025-12-31
$-4.43
2025-09-30
$-4.66
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$5.91M
2026-03-31
-$8.88M
2025-12-31
-$25.95M
2025-09-30
-$6.78M
Effective Tax Rate
2026-06-30
-0.3%
2026-03-31
0%
2025-12-31
1.8%
2025-09-30
16.53%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $166.13K | $145.95K | $263.92K | $145.38K |
| Operating Expenses | $6.32M | $8.9M | $7.78M | $7.13M |
| Net Income | -$6.28M | -$9.14M | -$25.74M | -$5.88M |
| Net Profit Margin | -3.78K% | -6.26K% | -9.75K% | -4.04K% |
| Earnings Per Share | $-1.46 | $-4.09 | $-4.43 | $-4.66 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$5.91M | -$8.88M | -$25.95M | -$6.78M |
| Effective Tax Rate | -0.3% | 0% | 1.8% | 16.53% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.